BFA
CLCD

BlackRock Fund Advisors’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

BlackRock Fund Advisors’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$10.1M Buy
276,194
+267,629
+3,125% +$9.47M ﹤0.01% 2569
2016
Q3 		$327K Buy
8,565
+68
+0.8% +$1K ﹤0.01% 3314
2016
Q2 		$69K Sell
8,497
-126
-1% -$846 ﹤0.01% 3758
2016
Q1 		$53K Sell
8,623
-534
-6% -$3.34K ﹤0.01% 3788
2015
Q4 		$77K Buy
+9,157
New +$48.2K ﹤0.01% 3795

Other funds holding CLCD

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

BlackRock Fund Advisors's CLCD Position: Q4 2016 in Review

BlackRock Fund Advisors increased its CoLucid Pharmaceuticals, Inc. (CLCD) stake by 3,125% in Q4 2016, buying an estimated $9.47M and bringing the position to 276,194 shares worth $10.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2569.

BlackRock Fund Advisors first reported a position in CLCD in Q4 2015 and has held it in 5 quarters since. 76 funds tracked by Wall St. Rank hold CLCD as of Q4 2016.

  • BlackRock Fund Advisors held 276,194 shares of CoLucid Pharmaceuticals, Inc. worth $10.1M as of Q4 2016.
  • BlackRock Fund Advisors bought 267,629 CoLucid Pharmaceuticals, Inc. shares in Q4 2016, an estimated $9.47M.
  • CoLucid Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2569 holding.
  • BlackRock Fund Advisors first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2015 and has held it in 5 quarters since.
  • 76 funds tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.